BRINGING YOU INFORMATION.  PROVIDING YOU A PLATFORM.

 

 
THE PHARMA REVIEW (MARCH APRIL 2015)

Pharmacovigilance: Ensuring Safe Use of Medicines

Ajay Kumar1, Shakti Balla2 & Pavan Malhotra3

Introduction: Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem particularly long term and short term adverse effect of medicines1. WHO established its Programme for International Drug Monitoring in response to the thalidomide disaster in 1961. Together with the WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden, WHO promotes pharmacovigilance at the country level. By the end of 2010, 134 countries were part of the WHO PV Programme. The aims of pharmacovigilance are to enhance patient care and patient safety in relation to the use of medicines; and to support public health programmes by providing reliable, balanced information for the effective assessment of the risk-benefit profile of medicines. (WHO; 2002).

 

Go to Content Index Page

PHARMA REVIEW - ARTICLES ARCHIVE ( COMPLETE LIST)

 

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 9811195411
Email: kongposhpub@gmail.com, Website: http://www.kppub.com

 
 
 
 

Copyright KONGPOSH PUBLICATIONS Pvt. Ltd.